Cargando…

Implementing Serosurveys in India: Experiences, Lessons Learned, and Recommendations

Serological surveillance for vaccine-preventable diseases, such as measles and rubella, can provide direct measures of population immunity across age groups, identify gaps in immunity, and document changes in immunity over time. Rigorously conducted, representative household serosurveys provide high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasan, Alvira Z., Kumar, Muthusamy Santhosh, Prosperi, Christine, Thangaraj, Jeromie Wesley Vivian, Sabarinathan, R., Saravanakumar, V., Duraiswamy, Augustine, Kaduskar, Ojas, Bhatt, Vaishali, Deshpande, Gururaj Rao, Ullas, Padinjaremattathil Thankappan, Sapkal, Gajanan N., Sangal, Lucky, Mehendale, Sanjay M., Gupta, Nivedita, Moss, William J., Hayford, Kyla, Murhekar, Manoj V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641364/ https://www.ncbi.nlm.nih.gov/pubmed/34607310 http://dx.doi.org/10.4269/ajtmh.21-0401

Ejemplares similares

Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India
por: Salvi, Neha, et al.
Publicado: (2022)

Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies
por: Kaduskar, Ojas, et al.
Publicado: (2021)

Diagnostic Accuracy of Dried Blood Spots Collected on HemaSpot HF Devices Compared to Venous Blood Specimens To Estimate Measles and Rubella Seroprevalence
por: Prosperi, Christine, et al.
Publicado: (2021)

Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018–2020
por: Murhekar, Manoj V, et al.
Publicado: (2022)

Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
por: Selvaraju, Sriram, et al.
Publicado: (2021)

Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020
por: Vivian Thangaraj, Jeromie Wesley, et al.
Publicado: (2021)

Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019–20
por: Shanmugasundaram, Devika, et al.
Publicado: (2021)

COVID-19 testing, timeliness and positivity from ICMR’s laboratory surveillance network in India: Profile of 176 million individuals tested and 188 million tests, March 2020 to January 2021
por: Ponnaiah, Manickam, et al.
Publicado: (2021)

Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant
por: Ullas, Padinjaremattathil Thankappan, et al.
Publicado: (2014)

Acceptability of serosurveys in southern Zambia: data collector and caregiver perspectives
por: Carcelen, Andrea C., et al.
Publicado: (2023)

COVID-19 serosurveys for public health decision making
por: Murhekar, Manoj V, et al.
Publicado: (2021)

Scrub Typhus as a Cause of Acute Encephalitis Syndrome, Gorakhpur, Uttar Pradesh, India
por: Mittal, Mahima, et al.
Publicado: (2017)

Enhanced SARS-CoV-2-Specific CD4(+) T Cell Activation and Multifunctionality in Late Convalescent COVID-19 Individuals
por: Pavan Kumar, Nathella, et al.
Publicado: (2022)

Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2021)

Characterization of memory T cell subsets and common γ−chain cytokines in convalescent COVID‐19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2022)

Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2022)

Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients
por: Kaduskar, Ojas, et al.
Publicado: (2022)

How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
por: Murhekar, Manoj V., et al.
Publicado: (2020)

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2021)

Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India
por: Potdar, Varsha, et al.
Publicado: (2020)

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey
por: Murhekar, Manoj V, et al.
Publicado: (2021)

Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
por: Deshpande, Gururaj Rao, et al.
Publicado: (2020)

Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018–20
por: Prosperi, C., et al.
Publicado: (2023)

Mapping dengue cases through a national network of laboratories, 2014-2015
por: Joshua, Vasna, et al.
Publicado: (2016)

Investigations of seasonal outbreaks of acute encephalitis syndrome due to Orientia tsutsugamushi in Gorakhpur region, India: A One Health case study
por: Murhekar, Manoj V., et al.
Publicado: (2021)

COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India
por: Jaiswal, Anoop, et al.
Publicado: (2021)

Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer
por: Ullas, Padinjaremattathil Thankappan, et al.
Publicado: (2014)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Deshpande, Gururaj Rao, et al.
Publicado: (2021)

Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020
por: Gupta, Nivedita, et al.
Publicado: (2020)

Recovery of Memory B-cell Subsets and Persistence of Antibodies in Convalescent COVID-19 Patients
por: Rajamanickam, Anuradha, et al.
Publicado: (2021)

Serosurvey for Nipah virus in bat population of southern part of India
por: Gokhale, Mangesh, et al.
Publicado: (2022)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

Exploration of population ecological factors related to the spatial heterogeneity of dengue fever cases diagnosed through a national network of laboratories in India, 2017
por: Joshua, Vasna, et al.
Publicado: (2020)

Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
por: Raju, Mohan Kumar, et al.
Publicado: (2022)

Dengue Serosurvey in Sint Eustatius
por: Leslie, Teresa, et al.
Publicado: (2014)

The 2015 influenza A (H1N1) pdm09 outbreak in India
por: Murhekar, Manoj, et al.
Publicado: (2016)

Dengue infection in India: A systematic review and meta-analysis
por: Ganeshkumar, Parasuraman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6fjvgcaicvae30hchm05v7mvij